775 related articles for article (PubMed ID: 23774534)
1. Cough, asthma, and cysteinyl-leukotrienes.
Niimi A
Pulm Pharmacol Ther; 2013 Oct; 26(5):514-9. PubMed ID: 23774534
[TBL] [Abstract][Full Text] [Related]
2. Clinical, physiological and anti-inflammatory effect of montelukast in patients with cough variant asthma.
Takemura M; Niimi A; Matsumoto H; Ueda T; Matsuoka H; Yamaguchi M; Jinnai M; Chin K; Mishima M
Respiration; 2012; 83(4):308-15. PubMed ID: 22094623
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of montelukast and airway mast cell profiles in patients with cough variant asthma.
Kawai S; Baba K; Matsubara A; Shiono H; Okada T; Yamaguchi E
J Asthma; 2008 Apr; 45(3):243-50. PubMed ID: 18415834
[TBL] [Abstract][Full Text] [Related]
4. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
[TBL] [Abstract][Full Text] [Related]
5. Leukotriene receptor antagonists pranlukast and montelukast for treating asthma.
Matsuse H; Kohno S
Expert Opin Pharmacother; 2014 Feb; 15(3):353-63. PubMed ID: 24350802
[TBL] [Abstract][Full Text] [Related]
6. Leukotriene receptor antagonists--risks and benefits for use in paediatric asthma.
Spahr JE; Krawiec ME
Expert Opin Drug Saf; 2004 May; 3(3):173-85. PubMed ID: 15155146
[TBL] [Abstract][Full Text] [Related]
7. Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma.
Yi F; Zhan C; Liu B; Li H; Zhou J; Tang J; Peng W; Luo W; Chen Q; Lai K
Respir Res; 2022 Oct; 23(1):279. PubMed ID: 36217131
[TBL] [Abstract][Full Text] [Related]
8. Montelukast in childhood asthma: what is the evidence for its use?
Amlani S; McIvor RA
Expert Rev Respir Med; 2011 Feb; 5(1):17-25. PubMed ID: 21348582
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of montelukast in the treatment of cough variant asthma.
Spector SL; Tan RA
Ann Allergy Asthma Immunol; 2004 Sep; 93(3):232-6. PubMed ID: 15478381
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic properties of leukotriene receptor antagonists.
Nicosia S
Monaldi Arch Chest Dis; 1999 Jun; 54(3):242-6. PubMed ID: 10441979
[TBL] [Abstract][Full Text] [Related]
11. Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast.
Minoguchi K; Kohno Y; Minoguchi H; Kihara N; Sano Y; Yasuhara H; Adachi M
Chest; 2002 Mar; 121(3):732-8. PubMed ID: 11888953
[TBL] [Abstract][Full Text] [Related]
12. Leukotriene modifiers in pediatric asthma management.
Bisgaard H
Pediatrics; 2001 Feb; 107(2):381-90. PubMed ID: 11158473
[TBL] [Abstract][Full Text] [Related]
13. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
Diamant Z; Grootendorst DC; Veselic-Charvat M; Timmers MC; De Smet M; Leff JA; Seidenberg BC; Zwinderman AH; Peszek I; Sterk PJ
Clin Exp Allergy; 1999 Jan; 29(1):42-51. PubMed ID: 10051701
[TBL] [Abstract][Full Text] [Related]
14. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
Fal AM; Kopeć A
Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521
[TBL] [Abstract][Full Text] [Related]
15. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
[TBL] [Abstract][Full Text] [Related]
16. Antitussive effects of the leukotriene receptor antagonist montelukast in patients with cough variant asthma and atopic cough.
Kita T; Fujimura M; Ogawa H; Nakatsumi Y; Nomura S; Ishiura Y; Myou S; Nakao S
Allergol Int; 2010 Jun; 59(2):185-92. PubMed ID: 20299826
[TBL] [Abstract][Full Text] [Related]
17. Montelukast: more than a cysteinyl leukotriene receptor antagonist?
Tintinger GR; Feldman C; Theron AJ; Anderson R
ScientificWorldJournal; 2010 Dec; 10():2403-13. PubMed ID: 21170491
[TBL] [Abstract][Full Text] [Related]
18. Effect of montelukast on exhaled leukotrienes and quality of life in asthmatic patients.
Biernacki WA; Kharitonov SA; Biernacka HM; Barnes PJ
Chest; 2005 Oct; 128(4):1958-63. PubMed ID: 16236841
[TBL] [Abstract][Full Text] [Related]
19. [The role of leukotrienes in inflammation and leukotriene inhibitors].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 1999 Sep; 7(39):85-93. PubMed ID: 10598480
[TBL] [Abstract][Full Text] [Related]
20. A review of montelukast in the treatment of asthma and allergic rhinitis.
Nayak A
Expert Opin Pharmacother; 2004 Mar; 5(3):679-86. PubMed ID: 15013935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
